KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Total Liabilities (2016 - 2026)

Evolent Health has reported Total Liabilities over the past 11 years, most recently at $1.5 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 9.69% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, up 9.69%, while the annual FY2025 figure was $1.5 billion, 9.69% up from the prior year.
  • Total Liabilities for Q4 2025 was $1.5 billion at Evolent Health, down from $1.6 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $1.6 billion in Q3 2025 and troughed at $646.0 million in Q3 2021.
  • A 5-year average of $1.1 billion and a median of $1.3 billion in 2023 define the central range for Total Liabilities.
  • On a YoY basis, Total Liabilities climbed as much as 205.0% in 2021 and fell as far as 12.35% in 2021.
  • Year by year, Total Liabilities stood at $725.8 million in 2021, then skyrocketed by 31.97% to $957.9 million in 2022, then soared by 49.73% to $1.4 billion in 2023, then fell by 5.66% to $1.4 billion in 2024, then rose by 9.69% to $1.5 billion in 2025.
  • Business Quant data shows Total Liabilities for EVH at $1.5 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.3 billion in Q2 2025.